| Company Structure |
|
Due to the diversity of the group, Litha Healthcare Group is divided into three Divisions. Each Division represents an industry sector and the technologies within each sector. Within each Division there are 100 % owned business units with the exception of The Biologicals and Vaccines Institute of Southern Africa (Pty) Ltd (The Biovac Institute) which is a Public Private Partnership (PPP) between the South African government and The Biovac Consortium. Each Division is headed by a Divisional CEO who manages the business units which make up their respective Divisions. |
South Africa enjoys a vibrant biotech industry with some companies specialising in research & development only and others having established manufacturing.
Litha prides itself in being a key player in the following Medical Devices market. The product sectors where we have established market share are:
The pharmaceutical industry in South Africa continues to grow despite concerns around medical inflation and the implementation of restrictive regulations. The burden of diseases like HIV/AIDS, TB and lifestyle diseases like Diabetes have boosted the demand and use of high priced medicines.
Copyright © 2011 Litha Healthcare Group Limited. All Rights Reserved.